Skip to main content

Free Content Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain

Download Article:
 Download
(PDF 67.4892578125 kb)
 
The susceptibility phenotypes of 964 clinical isolates of Mycobacterium tuberculosis were studied over a 7-year period in Seville, Spain. Thirty-eight (3.9%) strains were rifampin (RMP) resistant, 79 (8.2%) were isoniazid (INH) resistant and 22 (2.3%) were resistant to at least both antimicrobials (multidrug-resistant, MDR). We studied the mechanisms of resistance to these drugs in 94 resistant clinical isolates of M. tuberculosis using three molecular methods: 1) PCR-single strand conformation polymorphism (SSCP) analysis, 2) RFLP analysis using B1/B2 primers, and 3) sequence analysis. Five different mutations were detected in the rpoB gene: Ser531→Leu (72.3%), His526→Asp (12.8%), Asn518→Ser (2.1%), Gln513→Leu (2.1%) and a nine-nucleotide deletion (2.1%). In the case of resistance to INH, four different mutations in the katG gene were detected, Ser315→Thr (58.0%), Ser315→Leu (2.9%), partial deletion (5.8%) and Ile304→Val (1.4%), while in the inhA regulatory region the only mutation was the nucleotide substitution C209T (4.3%). No mutation was found in the ahpC promoter.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: M. tuberculosis; isoniazid resistance; katG; rifampin resistance; rpoB

Document Type: Short Communication

Affiliations: 1: Department of Microbiology, University of Seville School of Medicine, Seville, Spain 2: Department of Microbiology, University of Seville School of Medicine, Seville, Spain and Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain 3: Department of Microbiology, University of Seville School of Medicine, Seville, Spain and Hospital Universitario Virgen del Rocío, University of Seville, Seville, Spain

Publication date: 2002-02-01

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more